What this study is
Upper extremity allotransplantation is a new procedure which is becoming more common in the United States. Ongoing data collection for research purposes is vital to the long-term assessment as to the safety of the procedure and accompanying immunosuppression protocol, as well as quantifying patient outcomes and changes in quality of life. For these reasons, The Johns Hopkins Hand/Arm Transplantation Team is interested in enrolling transplanted patients in a follow-up protocol to continue collecting informative data to further the field of vascularized composite allotransplantation.
Study details
- Official title
- Human Upper Extremity Allotransplantation: Transplanted Patient Follow-Up Protocol
- Sponsor
- Johns Hopkins University
- Conditions
- Amputation, Traumatic · Wounds and Injury · Hand Injuries
- Enrolling
- 60 people
- Starts
- 2017-07-25
- Est. completion
- 2036-07-30
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 100 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Males and females 5 or more years post-unilateral or bilateral upper limb transplantation.
- Completes the protocol informed consent form.
- Consents to sample collection and storage (biopsies).
- USA citizen or equivalent.
- Patient agrees to comply with the protocol and states a dedication to the immunomodulatory treatment regime.
You can't join if
- Candidate has not received an upper extremity allotransplant.
- Any reason the study team thinks would cause the participant to be noncompliant or would put the patient at unacceptable risk if enrolled.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openJohns Hopkins University School of Medicine
Baltimore, Maryland, United States
- Carisa M Cooney, MPH, CCRP · Contact443-287-4629ccooney3@jhmi.edu
- TBD TBD · Contact443-287-7848
- Damon S Cooney, MD, PhD · Sub-investigator
- Jaimie Shores, MD · Principal investigator
- Richard J Redett, MD · Sub-investigator
Recruiting
Study team
Sponsor
Johns Hopkins University
Study ID NA_00068053
Principal investigator
Damon Cooney, M.D., Ph.D.
Johns Hopkins University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.